Organisation: Eisai

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

Irish Examiner view: Alzheimer’s drug brings hope for many

Sat, 01 Oct, 2022

Drug giants link up for data pool

Eight drug companies have agreed to create a pool of patented information to spur new research into 21 tropical diseases and conditions, UN officials have said.

Wed, 26 Oct, 2011

Elan sells Prialt rights to Japanese firm

ELAN has sold the European sales rights to its painkilling drug Prialt in a deal that could net the company €84 million.

Fri, 10 Feb, 2006

Elan sells epilepsy drug to Eisai

Troubled pharmaceutical company Elan has sold its interests in epilepsy drug Zonegran. Eisai will pay $130m to Elan if the transaction is completed by April 30 but less if the deal takes place after that.

Thu, 01 Apr, 2004

Elan aims to complete Zonegran deal in April

Pharmaceutical firm Elan has sold its interests in anti-epileptic drug Zonegran to Eisai for $130m (€106.41m) if the deal is finalised by the end of April.

Wed, 31 Mar, 2004